204 related articles for article (PubMed ID: 9818895)
1. Botulinum toxin type F for treatment of dystonia: long-term experience.
Chen R; Karp BI; Hallett M
Neurology; 1998 Nov; 51(5):1494-6. PubMed ID: 9818895
[TBL] [Abstract][Full Text] [Related]
2. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystonia.
Müller J; Wenning GK; Wissel J; Seppi K; Poewe W
J Neurol; 2002 Mar; 249(3):300-4. PubMed ID: 11993530
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia.
Lew MF; Adornato BT; Duane DD; Dykstra DD; Factor SA; Massey JM; Brin MF; Jankovic J; Rodnitzky RL; Singer C; Swenson MR; Tarsy D; Murray JJ; Koller M; Wallace JD
Neurology; 1997 Sep; 49(3):701-7. PubMed ID: 9305326
[TBL] [Abstract][Full Text] [Related]
5. Outcome of selective ramisectomy for botulinum toxin resistant torticollis.
Ford B; Louis ED; Greene P; Fahn S
J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):472-8. PubMed ID: 9771768
[TBL] [Abstract][Full Text] [Related]
6. [Botulinum toxin A: experience in the treatment of 115 patients].
Andrade LA; Borges V; Ferraz HB; Azevedo-Silva SM
Arq Neuropsiquiatr; 1997 Sep; 55(3B):553-7. PubMed ID: 9629404
[TBL] [Abstract][Full Text] [Related]
7. [Botulinum toxin in the treatment of focal dystonias: own experience with botulinum toxin].
Stefanoff P; Kiliszek M; Friedman A
Neurol Neurochir Pol; 2000; 34(1):61-70. PubMed ID: 10849905
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of focal dystonia with botulinum toxin A].
Sojer M; Wissel J; Müller J; Poewe W
Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
[TBL] [Abstract][Full Text] [Related]
9. Clinical application of botulinum toxin type B in movement disorders and autonomic symptoms.
Wan XH; Vuong KD; Jankovic J
Chin Med Sci J; 2005 Mar; 20(1):44-7. PubMed ID: 15844312
[TBL] [Abstract][Full Text] [Related]
10. Use of botulinum toxin injections for spasmodic torticollis of tardive dystonia.
Kaufman DM
J Neuropsychiatry Clin Neurosci; 1994; 6(1):50-3. PubMed ID: 8148637
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystonia.
Berman B; Seeberger L; Kumar R
Mov Disord; 2005 Feb; 20(2):233-7. PubMed ID: 15455449
[TBL] [Abstract][Full Text] [Related]
12. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
Cardoso F
Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
[TBL] [Abstract][Full Text] [Related]
13. Injection of botulinum toxin type B for the treatment of otolaryngology patients with secondary treatment failure of botulinum toxin type A.
Guntinas-Lichius O
Laryngoscope; 2003 Apr; 113(4):743-5. PubMed ID: 12671439
[No Abstract] [Full Text] [Related]
14. Botulinum toxin treatment of axial and cervical dystonia.
Benecke R; Dressler D
Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
[TBL] [Abstract][Full Text] [Related]
15. Treatment of cervical dystonia with botulinum toxin.
Jankovic J
Mov Disord; 2004 Mar; 19 Suppl 8():S109-15. PubMed ID: 15027062
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin A.
Sheean GL; Lees AJ
J Neurol Neurosurg Psychiatry; 1995 Dec; 59(6):601-7. PubMed ID: 7500097
[TBL] [Abstract][Full Text] [Related]
17. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
Brin MF; Fahn S; Moskowitz C; Friedman A; Shale HM; Greene PE; Blitzer A; List T; Lange D; Lovelace RE
Mov Disord; 1987; 2(4):237-54. PubMed ID: 3504553
[TBL] [Abstract][Full Text] [Related]
18. [Blepharospasm: treatment with botulinum toxin].
Barbosa ER; Silva HC; Haddad MS; Bittar MS
Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(6):220-3. PubMed ID: 9239894
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin in movement disorders.
Papapetropoulos S; Singer C
Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
Bhidayasiri R; Cardoso F; Truong DD
Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
